学校教师中过敏和喘患病率的差异
Hana B Ruran1, Briana L Mallouh2, Lisa M Bartnikas3
1Department of Medicine, Division of Immunology, Boston Children's Hospital, Boston, Mass; Case Western Reserve University School of Medicine, Cleveland, Ohio; Case Western Reserve University, Cleveland, Ohio.
The Journal of allergy and clinical immunology
|September 20, 2024
概括
农村和公立学校的教师报告的呼吸系统症状比郊区和私立学校的教师更多. 这表明教育工作者之间的健康差异需要进一步调查和解决方案.
科学领域:
- 环境健康 环境健康
- 职业健康 职业健康 职业健康
- 流行病学 流行病学
背景情况:
- 学校环境可能会影响学生的过敏疾病患病率.
- 关于学校因素如何影响教师健康的研究有限.
- 了解教师健康对于教育环境至关重要.
研究的目的:
- 为了比较城市,郊区和农村学校教师中过敏和呼吸道疾病的流行率.
- 根据学校的位置和类型,确定健康结果的潜在差异.
主要方法:
- 一项电子调查分发给一个随机样本的幼儿园前到12年级的教师在马萨诸塞州.
- 收集的数据包括教师人口统计和自我报告的过敏和呼吸系统症状.
- 在不同学校的人口统计数据和报告的健康问题之间进行了统计比较.
主要成果:
- 男老师报告说,喘息的频率比女老师更高 (P = .007).
- 农村教师 (54.54%) 比郊区教师 (34.61%) (P = .03) 经历了更多的呼吸系统症状,比如因咳而睡眠中断.
- 公立学校教师报告说,运动引起的胸痛 (48.26%) 比私立学校教师 (37.03%) (P = .05) 更多.
- 由于食物过敏,患有喘的城市教师比农村或郊区教师更容易错过学校 (P = .02).
- 在没有喘的教师中,缺课与夜间呼吸困难 (P < .0001),持续咳 (P = .002) 和喉疼痛 (P < .0001) 相相关.
结论:
- 与郊区和私立学校相比,农村和公立学校的教师报告的呼吸系统症状比例更高.
- 这些发现表明,根据学校的位置和类型,教师之间可能存在健康差异.
- 需要进一步的研究来开发基于证据的干预措施来解决这些差异.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245


